Jan Spanholtz

Jan Spanholtz

Technik-/Wissenschafts-/F&E-Leiter bei Glycostem Therapeutics BV

Health Technology

Ursprung des Netzwerks ersten Grades von Jan Spanholtz

EinheitArt der EinheitIndustrie
4
Holding Company Biotechnology 4

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Jan Spanholtz

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

Jan C. M. van der Hoeven

Director/Board Member

University of Hamburg College/University

Dirk Groenewegen

Doctorate Degree

Delft University of Technology College/University

Dirk Groenewegen

Graduate Degree

Investment Managers

Jan C. M. van der Hoeven

Private Equity Investor

Miscellaneous Commercial Services

Wim Jongen

President

Pharmaceuticals: Major

Jan C. M. van der Hoeven

Wim Jongen

Director/Board Member

Chairman

Chemicals: Major Diversified

Wim Jongen

Director/Board Member

Biotechnology

Jan C. M. van der Hoeven

Director/Board Member

Investment Managers

Jan C. M. van der Hoeven

Wim Jongen

Private Equity Investor

Private Equity Investor

Miscellaneous Commercial Services

Wim Jongen

Chairman

Wageningen University College/University

Jan C. M. van der Hoeven

Wim Jongen

Undergraduate Degree

Corporate Officer/Principal

Food: Major Diversified

Jan C. M. van der Hoeven

Director/Board Member

LAVA THERAPEUTICS N.V. Biotechnology

Jan C. M. van der Hoeven

Director/Board Member

Miscellaneous Commercial Services

Jan C. M. van der Hoeven

Director/Board Member

Medical/Nursing Services

Wim Jongen

Chairman

Statistik

International

Niederlande 17
Deutschland 2

Sektoral

Health Technology 6
Consumer Services 4
Finance 4
Commercial Services 4
Process Industries 2

Operativ

Director/Board Member 12
Private Equity Investor 4
Corporate Officer/Principal 3
Chairman 3
Doctorate Degree 2
  1. Börse
  2. Insiders
  3. Jan Spanholtz
  4. Unternehmensverbindungen